XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:      
Net income (loss) $ (10,500) $ 16,589 $ (34,021)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 179 419 774
(Gains) losses on sales of fixed assets   (125) 214
Intangible impairment charge 0 576 0
Deferred income tax 0 (228) 0
Change in contingent consideration liability 0 1,400 0
Expenses for share-based compensation awards   2,875 2,903
Acquisition of subsidiary escrow shares returned   (82) 0
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable   (38,788) 6,240
(Increase) decrease in other current assets   (2,259) 1,041
Decrease in other assets   2,208 0
(Decrease) in accounts payable and accrued expenses   (473) (2,565)
(Decrease) in deferred revenue - current   0 (833)
(Decrease) in other liabilities   (2) (163)
Net cash used in operating activities   (17,890) (26,410)
Cash flows from investing activities:      
Cash acquired in acquisition of subsidiary   0 1,888
Capital expenditures   (327) (77)
Proceeds from sales of fixed assets   128 153
Proceeds from redemption of auction rate securities   0 1,100
Net cash (used in) provided by investing activities   (199) 3,064
Cash flows from financing activities:      
Equity issuance costs in connection with acquisition of subsidiary   0 (45)
Proceeds from public offering of common stock, net of underwriting discounts and commissions and offering expenses   37,459 40,079
Proceeds from the exercise of stock options   0 71
Net cash provided by financing activities   37,459 40,105
Net increase in cash and cash equivalents   19,370 16,759
Cash and cash equivalents at beginning of period   65,860 58,838
Cash and cash equivalents at end of period 75,597 85,230 75,597
Supplemental disclosure of cash flow information:      
Contingent consideration liability 15,900 17,100 15,900
Stock acquisition consideration $ 11,265   $ 11,265